Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.32B |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$975M |
| 3 |
AABA
Altaba Inc
AABA
|
+$871M |
| 4 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$372M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$1.02B |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$860M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.12% |
| 2 | Healthcare | 4.92% |
| 3 | Financials | 4.07% |
| 4 | Consumer Discretionary | 3.64% |
| 5 | Communication Services | 3.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
CALL
Fomento Económico Mexicano
FMX
$41.7B
| $334K | ﹤0.01% |
3,400
+1,800
| +113% | +$168K |
|
3852
NBT Bancorp
NBTB
$2.74B
| $334K | ﹤0.01% |
9,021
+7,049
| +357% | +$262K |
|
3853
CALL
Insperity
NSP
$2.01B
| $334K | ﹤0.01% |
9,400
+8,800
| +1,467% | +$356K |
|
3854
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $334K | ﹤0.01% |
13,478
-366,577
| -96% | -$9.31M |
|
3855
CALL
ProShares UltraShort Silver
ZSL
$60M
| $334K | ﹤0.01% |
61
-2
| -3% | -$10.3K |
|
3856
Acadia Healthcare
ACHC
$2.94B
| $333K | ﹤0.01% |
6,749
-5,209
| -44% | -$231K |
|
|
CATM
3857
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $333K | ﹤0.01% |
10,127
-4,261
| -30% | -$160K |
|
|
EVRI
3858
DELISTED
Everi Holdings
EVRI
| $332K | ﹤0.01% |
45,718
-42,286
| -48% | -$274K |
|
3859
PUT
Teekay
TK
$985M
| $332K | ﹤0.01% |
49,800
+13,900
| +39% | +$103K |
|
3860
Universal Electronics
UEIC
$61.3M
| $332K | ﹤0.01% |
4,978
+4,708
| +1,744% | +$313K |
|
|
ABB
3861
DELISTED
ABB Ltd
ABB
| $332K | ﹤0.01% |
13,332
+8,732
| +190% | +$214K |
|
3862
Karyopharm Therapeutics
KPTI
$48M
| $331K | ﹤0.01% |
2,440
+1,396
| +134% | +$207K |
|
|
MANT
3863
DELISTED
Mantech International Corp
MANT
| $331K | ﹤0.01% |
8,004
+4,363
| +120% | +$165K |
|
|
NUTR
3864
DELISTED
Nutraceutical International Co
NUTR
| $331K | ﹤0.01% |
7,951
+7,808
| +5,460% | +$279K |
|
3865
Valley National Bancorp
VLY
$8.04B
| $330K | ﹤0.01% |
27,952
-10,001
| -26% | -$117K |
|
3866
Geron
GERN
$949M
| $329K | ﹤0.01% |
118,782
-17,333
| -13% | -$46K |
|
|
GREK
3867
Global X MSCI Greece ETF
GREK
$329M
| $328K | ﹤0.01% |
10,827
-1,667
| -13% | -$45.8K |
|
3868
Stewart Information Services
STC
$2.08B
| $328K | ﹤0.01% |
7,204
+5,787
| +408% | +$261K |
|
3869
BlackLine
BL
$1.72B
| $327K | ﹤0.01% |
9,150
-1,105
| -11% | -$36.6K |
|
3870
Enova International
ENVA
$6.29B
| $327K | ﹤0.01% |
22,066
-28,509
| -56% | -$403K |
|
|
LABL
3871
DELISTED
Multi-Color Corp
LABL
| $327K | ﹤0.01% |
4,008
+3,418
| +579% | +$270K |
|
|
3872
CALL
Karyopharm Therapeutics
KPTI
$48M
| $326K | ﹤0.01% |
+2,400
| New | +$355K |
|
|
3873
PUT
Karyopharm Therapeutics
KPTI
$48M
| $326K | ﹤0.01% |
+2,400
| New | +$355K |
|
3874
Grand Canyon Education
LOPE
$3.98B
| $326K | ﹤0.01% |
4,144
-397
| -9% | -$30.4K |
|
|
NBLX
3875
DELISTED
Noble Midstream Partners LP
NBLX
| $326K | ﹤0.01% |
7,182
-10,718
| -60% | -$510K |
|
Similar funds
Barclays's Q2 2017 Portfolio in Review
As of Q2 2017, Barclays held 7,324 positions worth $93.4B, up 1.6% from $91.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays's Q2 2017 filing shows 436 new, 3,303 increased, 2,734 reduced and 395 closed positions. Its largest new stake was Altaba Inc: 16,007,195 shares worth $872M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.62B.
By sector, the portfolio is most concentrated in Technology at 6.1% of assets, up from 5.7% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q2 2017 buy was Altaba Inc: 16,007,195 shares worth $872M.
- Barclays added most to Invesco QQQ Trust in Q2 2017, an estimated $3.32B increase.
- Barclays's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.62B.
- Barclays fully exited Yahoo Inc in Q2 2017, selling an estimated $174M.
- Barclays's ten largest holdings make up 32% of its $93.4B portfolio in Q2 2017.
- Barclays opened 436 new positions and closed 395 in Q2 2017.
- Barclays's portfolio value rose 1.6% quarter-over-quarter to $93.4B.
Based on Barclays's 13F filing for Q2 2017, filed 14 Aug 2017.